Natixis Reduces Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Natixis cut its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 36.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 30,428 shares of the biotechnology company's stock after selling 17,375 shares during the quarter. Natixis' holdings in Axon Enterprise were worth $18,084,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. New Wave Wealth Advisors LLC bought a new position in shares of Axon Enterprise during the fourth quarter valued at approximately $40,000. Y.D. More Investments Ltd purchased a new position in shares of Axon Enterprise in the 4th quarter valued at $45,000. Stonebridge Financial Group LLC bought a new position in shares of Axon Enterprise in the 4th quarter worth $53,000. GPS Wealth Strategies Group LLC lifted its position in shares of Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after buying an additional 40 shares during the last quarter. Finally, Versant Capital Management Inc lifted its position in Axon Enterprise by 4,750.0% during the fourth quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock valued at $58,000 after acquiring an additional 95 shares during the last quarter. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON traded up $13.77 during trading on Thursday, hitting $590.67. The company had a trading volume of 493,169 shares, compared to its average volume of 780,024. The firm has a market capitalization of $45.98 billion, a price-to-earnings ratio of 152.63, a price-to-earnings-growth ratio of 5.17 and a beta of 1.13. The stock has a fifty day simple moving average of $549.49 and a two-hundred day simple moving average of $568.33. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a fifty-two week low of $273.52 and a fifty-two week high of $715.99.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. JMP Securities restated an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. TD Cowen started coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a report on Monday, January 27th. Craig Hallum lowered Axon Enterprise from a "buy" rating to a "cautious" rating in a research note on Monday, March 10th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday. One analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $626.45.

Insiders Place Their Bets

In related news, Director Jeri Williams sold 307 shares of the business's stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total transaction of $169,685.04. Following the transaction, the director now directly owns 1,627 shares in the company, valued at approximately $899,275.44. The trade was a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction dated Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the completion of the sale, the chief executive officer now owns 3,063,982 shares of the company's stock, valued at approximately $1,657,583,622.18. The trade was a 0.33 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.